Search research articles
Contact Us
Filters
Showing results (261-270 of 268) with videos related to
Page
of 27
Sort By:
You have reached the last page of results.
This site can display upto 268 results.
Cancer Discovery
|
September 28, 2015
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K Brastianos, Scott L Carter, Sandro Santagata, et al.
Neuro-Oncology
|
August 19, 2025
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions
Patrick Y Wen, Michael Weller, Eudocia Q Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
Patrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization
Rifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
Cell
|
July 23, 2019
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel, Julie Laffy, Mariella G Filbin, et al.
Nature
|
April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat, Yvonne Y Li, Adam N Boynton, et al.
Cancer Discovery
|
August 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Cancer Discovery
|
March 3, 2025
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Page
of 27
Search research articles
Search
Showing results (261-270 of 268) with videos related to
Sort By:
Page
of 27
You have reached the last page of results.
This site can display upto 268 results.
Cancer Discovery
|
September 28, 2015
Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
Priscilla K Brastianos, Scott L Carter, Sandro Santagata, et al.
Neuro-Oncology
|
August 19, 2025
Glioblastoma in Adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) Consensus Review on Current Management and Future Directions
Patrick Y Wen, Michael Weller, Eudocia Q Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 5, 2019
Buparlisib in Patients With Recurrent Glioblastoma Harboring Phosphatidylinositol 3-Kinase Pathway Activation: An Open-Label, Multicenter, Multi-Arm, Phase II Trial
Patrick Y Wen, Mehdi Touat, Brian M Alexander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 18, 2023
Inaugural Results of the Individualized Screening Trial of Innovative Glioblastoma Therapy: A Phase II Platform Trial for Newly Diagnosed Glioblastoma Using Bayesian Adaptive Randomization
Rifaquat Rahman, Lorenzo Trippa, Eudocia Q Lee, et al.
Cell
|
July 23, 2019
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel, Julie Laffy, Mariella G Filbin, et al.
Nature
|
April 24, 2020
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat, Yvonne Y Li, Adam N Boynton, et al.
Cancer Discovery
|
August 16, 2023
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Cancer Discovery
|
March 3, 2025
Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, et al.
Page
of 27